• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区糖尿病患者死亡率趋势:2000-2009 年全国性调查。

Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000-2009.

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

J Formos Med Assoc. 2012 Nov;111(11):645-50. doi: 10.1016/j.jfma.2012.09.013. Epub 2012 Nov 7.

DOI:10.1016/j.jfma.2012.09.013
PMID:23217600
Abstract

BACKGROUND/PURPOSE: Medical systems and care for diabetes have changed greatly in Taiwan in recent years. This study investigated mortality trends in patients with diabetes in Taiwan from 2000 to 2009.

METHODS

We linked the National Health Insurance (NHI) claims database, which contains data on 99% of the population of Taiwan, to the National Death Registry and Cancer Registry. Patients were classified as having diabetes if they had at least one hospital admission or three or more outpatient visits with a diabetes diagnostic code in each calendar year. Mortality data from the Collaboration Center of Health Information Application were used to estimate age- and sex-specific mortality rates, all-cause mortality, and life expectancy (LE).

RESULTS

The mortality of patients with diabetes in Taiwan decreased continuously from 2000 to 2009 for both sexes and all age groups; the mortality rate was generally higher for men than for women (3.92% vs. 3.29% in 2000; 3.64% vs. 3.11% in 2005, and 3.12% vs. 2.71% in 2009, all p < 0.05). Diabetic patients had a shorter LE than the entire population, although this difference decreased over time. The estimated loss of life due to diabetes was 6.1 years in women and 5.3 years in men in 2009, when diabetes was diagnosed at the age of 40. The four major causes of death were diabetes, malignancies, heart diseases, and cerebrovascular diseases.

CONCLUSION

The mortality of diabetic patients in Taiwan decreased from 2000 to 2009. Although patients with diabetes had a shorter LE than the entire population, the difference decreased over time.

摘要

背景/目的:近年来,台湾的医疗体系和糖尿病护理发生了巨大变化。本研究调查了 2000 年至 2009 年台湾糖尿病患者的死亡率趋势。

方法

我们将国家健康保险(NHI)理赔数据库与国家死亡登记处和癌症登记处相关联,该数据库包含了台湾 99%人口的数据。如果患者在每个日历年内至少有一次住院或三次或更多次门诊就诊且有糖尿病诊断代码,则将其归类为患有糖尿病。来自合作健康信息应用中心的数据用于估计按年龄和性别划分的死亡率、全因死亡率和预期寿命(LE)。

结果

台湾的糖尿病患者死亡率从 2000 年到 2009 年持续下降,无论是男性还是女性,所有年龄段的死亡率普遍较高;男性的死亡率高于女性(2000 年为 3.92%,3.64%;2005 年为 3.29%,3.11%;2009 年为 3.12%,2.71%,均<0.05)。与整个人群相比,糖尿病患者的 LE 更短,尽管这种差异随着时间的推移而缩小。2009 年,当糖尿病患者在 40 岁时被诊断出来时,女性因糖尿病导致的预期寿命损失为 6.1 年,男性为 5.3 年。导致死亡的四个主要原因是糖尿病、恶性肿瘤、心脏病和脑血管疾病。

结论

台湾糖尿病患者的死亡率从 2000 年到 2009 年下降。尽管与整个人群相比,糖尿病患者的 LE 更短,但这种差异随着时间的推移而缩小。

相似文献

1
Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000-2009.台湾地区糖尿病患者死亡率趋势:2000-2009 年全国性调查。
J Formos Med Assoc. 2012 Nov;111(11):645-50. doi: 10.1016/j.jfma.2012.09.013. Epub 2012 Nov 7.
2
Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005-2014.台湾地区糖尿病患者死亡率趋势:2005-2014 年全国性调查。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S83-S89. doi: 10.1016/j.jfma.2019.07.008. Epub 2019 Jul 24.
3
Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.台湾地区糖尿病发病率和流行率分析:2000-2009 年全民健康保险数据库资料。
J Formos Med Assoc. 2012 Nov;111(11):599-604. doi: 10.1016/j.jfma.2012.09.014. Epub 2012 Oct 23.
4
Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database.2000-2009 年台湾地区糖尿病管理的问责制、利用率和提供者:国家健康保险数据库分析。
J Formos Med Assoc. 2012 Nov;111(11):605-16. doi: 10.1016/j.jfma.2012.09.011. Epub 2012 Oct 31.
5
Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.台湾地区糖尿病患者中高血压和血脂异常的流行情况及其与微血管和大血管疾病的关系:2000-2009 年全国数据分析。
J Formos Med Assoc. 2012 Nov;111(11):625-36. doi: 10.1016/j.jfma.2012.09.010. Epub 2012 Nov 27.
6
Trends in death rate from diabetes according to multiple-cause-of-death differed from that according to underlying-cause-of-death in Taiwan but not in the United States, 1987-2007.1987-2007 年,台湾地区糖尿病死亡率的多死因趋势与根本死因趋势不同,但美国并非如此。
J Clin Epidemiol. 2012 May;65(5):572-6. doi: 10.1016/j.jclinepi.2011.09.010. Epub 2012 Jan 24.
7
Gender differences in the impact of diabetes on mortality in patients with established coronary artery disease: a report from the eastern Taiwan integrated health care delivery system of Coronary Heart Disease (ET-CHD) registry, 1997-2006.糖尿病对已确诊冠心病患者死亡率影响的性别差异:来自台湾东部整合医疗照护体系冠心疾病(ET-CHD)登记处,1997-2006 年的报告。
J Cardiol. 2013 Jun;61(6):393-8. doi: 10.1016/j.jjcc.2013.02.007. Epub 2013 Mar 15.
8
Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.台湾健康保险理赔数据中糖尿病诊断的准确性。
J Formos Med Assoc. 2005 Mar;104(3):157-63.
9
Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years.1型糖尿病的预期寿命和终身医疗保健支出:一项对新发病例进行了14年随访的全国性纵向队列研究。
Value Health. 2016 Dec;19(8):976-984. doi: 10.1016/j.jval.2016.05.017. Epub 2016 Jul 29.
10
Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan.2005 年至 2014 年台湾地区糖尿病患病率和发病率趋势。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S66-S73. doi: 10.1016/j.jfma.2019.06.016. Epub 2019 Jul 9.

引用本文的文献

1
Application of type II diabetes incidence and mortality rates for insurance.用于保险的 II 型糖尿病发病率和死亡率的应用。
PLoS One. 2024 Sep 25;19(9):e0307508. doi: 10.1371/journal.pone.0307508. eCollection 2024.
2
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.在高收入国家,不同发病年龄的 2 型糖尿病患者的预期寿命:2300 万人年的观察结果。
Lancet Diabetes Endocrinol. 2023 Oct;11(10):731-742. doi: 10.1016/S2213-8587(23)00223-1. Epub 2023 Sep 11.
3
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
恩格列净在东亚常规治疗中与心血管事件和全因死亡率降低相关:来自 EMPRISE 研究的结果。
J Diabetes Investig. 2023 Mar;14(3):417-428. doi: 10.1111/jdi.13959. Epub 2023 Jan 30.
4
Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England.2 型糖尿病患者癌症死亡率趋势的不平等:英国 20 年基于人群的研究。
Diabetologia. 2023 Apr;66(4):657-673. doi: 10.1007/s00125-022-05854-8. Epub 2023 Jan 24.
5
Relationship between Leptin and Insulin Resistance among Community-Dwelling Middle-Aged and Elderly Populations in Taiwan.台湾社区中老年人群中瘦素与胰岛素抵抗的关系。
J Clin Med. 2022 Sep 13;11(18):5357. doi: 10.3390/jcm11185357.
6
Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan.2007 年至 2018 年间台湾地区糖尿病患者全因死亡率和主要死因的变化趋势。
Front Endocrinol (Lausanne). 2022 Aug 9;13:984137. doi: 10.3389/fendo.2022.984137. eCollection 2022.
7
Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.当考虑到糖尿病共存的影响时,在接受常规治疗的帕金森病患者中添加艾塞那肽的成本效益。
PLoS One. 2022 Aug 11;17(8):e0269006. doi: 10.1371/journal.pone.0269006. eCollection 2022.
8
Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy.循环生长分化因子15与糖尿病性神经病变相关。
J Clin Med. 2022 May 27;11(11):3033. doi: 10.3390/jcm11113033.
9
The Impact of Diabetes on Vascular Disease: Progress from the Perspective of Epidemics and Treatments.糖尿病对血管疾病的影响:从流行病学和治疗角度看进展
J Diabetes Res. 2022 Apr 8;2022:1531289. doi: 10.1155/2022/1531289. eCollection 2022.
10
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study.在使用二甲双胍治疗的糖尿病患者中,早期胰岛素治疗与格列美脲治疗的影响:一项全国性回顾性队列研究。
Medicine (Baltimore). 2021 Mar 5;100(9):e25085. doi: 10.1097/MD.0000000000025085.